126 related articles for article (PubMed ID: 19059330)
1. APOE polymorphism affects episodic memory among non demented elderly subjects.
De Blasi S; Montesanto A; Martino C; Dato S; De Rango F; Bruni AC; Mari V; Feraco E; Passarino G
Exp Gerontol; 2009 Mar; 44(3):224-7. PubMed ID: 19059330
[TBL] [Abstract][Full Text] [Related]
2. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
4. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
6. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
8. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
[TBL] [Abstract][Full Text] [Related]
9. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
10. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J; Fisk JD
Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
[TBL] [Abstract][Full Text] [Related]
11. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E and prospective memory in normally aging adults.
Driscoll I; McDaniel MA; Guynn MJ
Neuropsychology; 2005 Jan; 19(1):28-34. PubMed ID: 15656760
[TBL] [Abstract][Full Text] [Related]
16. Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population.
Payton A; van den Boogerd E; Davidson Y; Gibbons L; Ollier W; Rabbitt P; Worthington J; Horan M; Pendleton N
Genes Brain Behav; 2006; 5 Suppl 1():23-31. PubMed ID: 16417614
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
19. Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline.
Sachs-Ericsson N; Corsentino E; Collins N; Sawyer K; Blazer DG
Aging Ment Health; 2010 Mar; 14(2):138-44. PubMed ID: 19946803
[TBL] [Abstract][Full Text] [Related]
20. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
